Fredericus Colen
Direktor/Vorstandsmitglied bei ONWARD MEDICAL N.V.
Vermögen: 356 081 $ am 30.04.2024
Profil
Fredericus Antonius Colen is currently the Chairman at Xeltis AG, the Director at the College of Science & Engineering, an Independent Non-Executive Director at Onward Medical NV, a Director at Onward Medical SA, and an Independent Director at Volato Group, Inc. Previously, he held positions such as Chairman, President & Chief Executive Officer at BeneChill, Inc., Chief Executive Officer at Acarix AB, President & Chief Executive Officer at Neovasc, Inc., Director at Mölnlycke Health Care AB, Independent Director at Middle Peak Medical, Inc., and Vice President at the International Association of Medical Prosthesis Manufacturers.
He also served as the Chief Technology Officer & Executive VP at Boston Scientific Corp.
and as the President of Cardiac Rhythm Management.
Mr. Colen obtained a graduate degree from RWTH Aachen University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONWARD MEDICAL N.V.
0,20% | 25.03.2024 | 69 962 ( 0,20% ) | 356 081 $ | 30.04.2024 |
Aktive Positionen von Fredericus Colen
| Unternehmen | Position | Beginn |
|---|---|---|
| ONWARD MEDICAL N.V. | Direktor/Vorstandsmitglied | 01.01.2017 |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Direktor/Vorstandsmitglied | 01.01.2017 |
| College of Science & Engineering | Direktor/Vorstandsmitglied | - |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Vorsitzender | 01.01.2023 |
Ehemalige bekannte Positionen von Fredericus Colen
| Unternehmen | Position | Ende |
|---|---|---|
| ACARIX AB | Vorstandsvorsitzender | 01.02.2024 |
| NEOVASC INC. | Vorstandsvorsitzender | 01.04.2023 |
Mölnlycke Health Care AB
 Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | Direktor/Vorstandsmitglied | 01.03.2017 |
Middle Peak Medical, Inc.
 Middle Peak Medical, Inc. Medical SpecialtiesHealth Technology Middle Peak Medical, Inc. develops implants for treatment of mitral valve disease. Its technology has application in both percutaneous catheter-based intervention and in minimally invasive or open-heart cardiac surgery. The company was founded by Michael D. Lesh and Alexander Khairkhahan in 2011 and is headquartered in Palo Alto, CA. | Direktor/Vorstandsmitglied | 01.02.2017 |
BeneChill, Inc.
 BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA. | Vorstandsvorsitzender | 01.03.2016 |
Ausbildung von Fredericus Colen
| RWTH Aachen University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| ACARIX AB | Health Technology |
| ONWARD MEDICAL N.V. | Commercial Services |
| Private Unternehmen | 9 |
|---|---|
SCIMED Life Systems, Inc. (Minnesota)
 SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Health Technology |
BeneChill, Inc.
BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA. | Health Technology |
Cardiac Rhythm Management
 Cardiac Rhythm Management Medical SpecialtiesHealth Technology Part of Japan Lifeline Co., Ltd., Cardiac Rhythm Management is a company that manufactures implantable devices to treat arrhythmias. The company is based in Sylmar, CA. | Health Technology |
| International Association of Medical Prosthesis Manufacturers | |
Neovasc, Inc.
 Neovasc, Inc. Medical SpecialtiesHealth Technology Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. | Health Technology |
Mölnlycke Health Care AB
Mölnlycke Health Care AB Medical SpecialtiesHealth Technology Mölnlycke Health Care AB manufactures surgical and wound care products. It offers custom procedure trays, examination gloves, dental products, staff clothing, surgical drapes and absorbent dressings. The firm's brands include BARRIER, Biogel, HiBi and ProcedurePak, Mepilex, Mepitel, Mepore, Mefix, Tubifast, Tubigrip and Xelma. The company was founded by Gustaf Ferdinand Hennig in 1849 and is headquartered in Goteborg, Sweden. | Health Technology |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
Middle Peak Medical, Inc.
Middle Peak Medical, Inc. Medical SpecialtiesHealth Technology Middle Peak Medical, Inc. develops implants for treatment of mitral valve disease. Its technology has application in both percutaneous catheter-based intervention and in minimally invasive or open-heart cardiac surgery. The company was founded by Michael D. Lesh and Alexander Khairkhahan in 2011 and is headquartered in Palo Alto, CA. | Health Technology |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Health Technology |
